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Generalized borreliosis with CNS and joints involvement
was diagnosed.
Case 3: A 31 years old woman presented severe pain
NCS=8 points in anterior femoral region. No tick bite was
noticed. EM was recognized. Analgesic treatment did not
cause any alleviation of pain. Physical examination showed
skin paresthesia corresponding to region of pain. The anti-
bodies against B.b. were detected in serum, conﬁrmed by
W.b. assay. Femoral nerve radiculopathy in course of neu-
roborreliosis was diagnosed. All patients were treated with
antibiotics: ceftriaxone.
Conclusion: In cases, when pathomechanism of pain is
difﬁcult to understand, neuroborreliosis should be included
as one of differential diagnosis. The real diagnosis and
treatment result in complete withdrawal of pain and other
clinical symptoms.
doi:10.1016/j.ijid.2010.02.506
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The emerging of non-AIDS related neoplasms in the era of
combined antiretroviral therapy
R. Manfredi
University of Bologna, Bologna, Italy
Background: The introduction of combined antiretroviral
therapy (cART) since the year 1996, contributed to a rapid,
signiﬁcant drop of frequency of all AIDS-deﬁning opportunis-
tic infections and some selected AIDS-related tumors (like
Kaposi’sarcoma), with a consequent, remarkable reduction
of both morbidity and mortality rates associated with these
disease complications.
Methods: Our cohort of over 1,700 HIV-infected patients
followed in two connected outpatient centres by the
same physician staff were prospectively followed since
the year 2000 (9 years), with special interest focused on
the diagnosis, treatment and outcome of non-AIDS related
malignancies.
Results: Among hematological malignancies other than
non-Hodgkin’s lymphoma and primary central nervous
system lymphoma, we observed three cases of acute myel-
ogenic leukaemia and 4 episodes of Hodgkin’s lymphoma. A
greater number of solid tumors involved different organs
and sites: laryngeal cancer (8 cases, with 6 episodes of
papillomatous laryngeal cancer), rhinopharyngeal squamous
carcinoma (4 cases), adenocarcinoma of the lung (6 cases),
gastric adenocarcinoma (3 episodes), esophageal carcinoma
(2 patients), prostate cancer (4 cases), bladder adnocar-
cinoma (3 episodes) pancreatic adenocarcinoma (2 cases),
and squamos anal carcinoma (2 episodes). Some of these
malignancies have been reported with extremely rare fre-
quency until now (usually as single-case anecdotal reports),
in particular before the cART era. The patient’s age ranged
from 34 to 67 years, the mortality rate of these episodes
was very elevated (over 80%), and occurred 3-41 months
after diagnosis, despite appropriate surgical and/or cyto-
toxic chemotherapy and/or radiotherapy.
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Conclusion: The signiﬁcantly increased life expectancy
f HIV infected patients in the cART era was charac-
erized by a proportionally increase of non-AIDS-deﬁning
umors, which may depend on the advanced mean patients’
ge, their prolonged exposure to risk factor, the persist-
ng functional immune system imbalance, and probably
ome direct oncogenic property of HIV itself, even when
‘‘quantitative’’ recovery of CD4+ lymphocyte count has
een achieved thanks to cART. The differential diagnosis
f non-AIDS-associated tumors may be delayed by the low
linical suspicion, and their frequency to mimick and/or
verlap infectious complications. Further epidemiological
nd clinical investigation is strongly warranted, to increase
he awareness of this emerging phenomenon.
oi:10.1016/j.ijid.2010.02.507
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Background: Tuberculosis and AIDS are considered to be a
‘deadly synergy’’ among HIVinfected children in Southeast
sia and sub-Saharan Africa.
Methods: We have assessed a cohort of 118 HIV-infected
hildren, 72 of them receive antiretroviral therapy (HAART)
or an average of 38 months (12-63 months), for the preva-
ence of tuberculosis, anti-tuberculosis therapy, immune
esponse to HAART and coincidence of other opportunistic
nfections. Table 1 shows a cohort of 40 HIV-infected chil-
ren with tuberculosis (36 pulmonary and 4 extrapulmonary)
ompared to 32 HIV — infected children without tuberculosis
ut with AIDS and other opportunistic infections.
Results: Children with tuberculosis were signiﬁcantly
ounger (P<0.01) (7.8 vs. 12.8 years) and had signiﬁcantly
ower CD4 absolute count (180 vs. 302) in comparison to
IV-infected children without tuberculosis. Immune cate-
ory 3 (82.5% vs. 59,4%, P<0.05) and CDC category C (45% vs.
.4%, P<0.001) were also more frequently observed among
IV-infected children with tuberculosis.
Proportion of deaths (3 children within 5 years within
2 children on HAART) or treatment failure on 1-st line
AART (6 children) was similar in both groups of children
with tuberculosis and without tuberculosis). Frequency of
pportunistic infections (more than 5 per year) among tuber-
ulosis children cohort was also higher among tuberculosis
IV-infected children (70% vs. 21,9%, P<0.001). Otitis media
55% vs. 31,1% P<0.05), oropharyngeal candidiasis (45% vs.
1,9% P<0.04), Immune reconstruction syndrome (IRS) (40%
s. 12,5%, P<0.001) occurred signiﬁcantly more frequently
n HIV-infected children with tuberculosis in comparison to
hildren without tuberculosis. Anti tuberculosis treatment
Isoniazide + Rifampin + Pyrazinamid) was given 4-8 weeks
efore onset of HAART (lamivudine + didanosin + efavirens),
o decrease the probability of IRS. Most children received 6
onths treatment with Isoniazide + Rifampin + Pyrazinamid
60%) or Ethambutol (40% children older than 10 years), 7-9
